Atlas Trials

TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia

Clinical trial NCT04692948 · UNKNOWN

Trial details

NCT number
NCT04692948
Sponsor
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
CARAcute Myeloid Leukemia
Start date
2019-12-09
Primary completion
2021-12-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.